{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:39:08Z","timestamp":1790804348398,"version":"4.1.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Non-mutated FVIII-specific CD4 T cell epitopes have been recently found to contribute to the development of inhibitors in patients with hemophilia A (HA), while auto-reactive CD4 T cells specific to FVIII circulate in the blood of healthy individuals at a frequency close to the foreign protein ovalbumin. Thus, although FVIII is a self-protein, the central tolerance raised against FVIII appears to be low. In this study, we conducted a comprehensive analysis of the FVIII CD4 T cell repertoire in 29 healthy donors. Sequencing of the CDR3\u03b2 TCR region from isolated FVIII-specific CD4 T cells revealed a limited usage and pairing of TRBV and TRBJ genes as well as a mostly hydrophobic composition of the CDR3\u03b2 region according to their auto-reactivity. The FVIII repertoire is dominated by a few clonotypes, with only 13 clonotypes accounting for half of the FVIII response. Through a large-scale epitope mapping of the full-length FVIII sequence, we identified 18 immunodominant epitopes located in the A1, A3, C1, and C2 domains and covering half of the T cell response. These epitopes exhibited a broad specificity for HLA-DR or DP molecules or both. T cell priming with this reduced set of peptides revealed that highly expanded clonotypes specific to these epitopes were responsible individually for up to 32% of the total FVIII repertoire. These FVIII T cell epitopes and clonotypes were shared among HLA-unrelated donors tested and previously reported HA patients. Our study highlights the role of the auto-reactive T cell response against FVIII in HA and its similarity to the response observed in healthy individuals. Thus, it provides valuable insights for the development of new tolerance induction and deimmunization strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1345195","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:01:40Z","timestamp":1709701300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes"],"prefix":"10.3389","volume":"15","author":[{"given":"Valeria","family":"Porcheddu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautier","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Giraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Maill\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.206383","article-title":"Pathogenic immune response to therapeutic factor viii: exacerbated response or failed induction of tolerance","volume":"2","author":"Varthaman","year":"2018","journal-title":"Haematologica"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-412361","article-title":"A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function","volume":"120","author":"Meeks","year":"2012","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/ph15080911","article-title":"Immunogenicity of current and new therapies for hemophilia A","volume":"15","author":"Prezotti","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2450\/2023.0247-22","article-title":"Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding","volume":"21","author":"Pasca","year":"2023","journal-title":"Blood Transfusion"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14638","article-title":"Management of haemophilia a with inhibitors: A regional cross-talk","volume":"6","author":"Peyvandi","year":"2022","journal-title":"Haemophilia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor viii: recent progress","volume":"10","author":"Lacroix-Desmazes","year":"2020","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420408","article-title":"Loss of high-responder inhibitors in patients with severe hemophilia a and human immunodeficiency virus type 1 infection: A report from the multi-center hemophilia cohort study","volume":"4","author":"Bray","year":"1993","journal-title":"Am J Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2456","article-title":"Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders","volume":"104","author":"Hausl","year":"2004","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2207","article-title":"In vivo neutralization of a C2 domain\u2013specific human anti\u2013Factor VIII inhibitor by an anti-idiotypic antibody","volume":"103","author":"Gilles","year":"2004","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V92.2.496","article-title":"Mechanism and kinetics of factor VIII inactivation: study with an igG4 monoclonal antibody derived from a hemophilia A patient with inhibitor","volume":"92","author":"Jacquemin","year":"1998","journal-title":"Blood"},{"key":"B11","article-title":"Distribution of th1- and th2-induced anti-factor VIII igG subclasses in congenital and acquired hemophilia patients","volume":"88","author":"Reding","year":"2002","journal-title":"Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.2.558","article-title":"Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes","volume":"95","author":"Van Den Brink","year":"2000","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1128641","article-title":"Hemophilia A subjects with an intron-22 gene inversion mutation show CD4+ T-effector responses to multiple epitopes in FVIII","volume":"14","author":"Gunasekera","year":"2023","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1369","article-title":"CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild\/moderate hemophilia A","volume":"101","author":"Jacquemin","year":"2003","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S77332","article-title":"Acquired hemophilia A: emerging treatment options","volume":"6","author":"Janbain","year":"2015","journal-title":"J Blood Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.9.3795","article-title":"Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals","volume":"89","author":"Algiman","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005745","article-title":"Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors","volume":"6","author":"Schweiger","year":"2022","journal-title":"Blood Adv"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-444877","article-title":"Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients","volume":"121","author":"Whelan","year":"2013","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017008706","article-title":"CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise na\u00efve and memory cells","volume":"1","author":"Meunier","year":"2017","journal-title":"Blood Adv"},{"key":"B20","doi-asserted-by":"publisher","first-page":"102972","DOI":"10.1016\/j.ebiom.2020.102972","article-title":"Ultra-efficient sequencing of T Cell receptor repertoires reveals shared responses in muscle from patients with Myositis","volume":"59","author":"Montagne","year":"2020","journal-title":"EBioMedicine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-173872","article-title":"Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies","volume":"25","author":"Delluc","year":"2011","journal-title":"FASEB J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1707418","DOI":"10.1080\/19420862.2019.1707418","article-title":"T cell epitope mapping of secukinumab and ixekizumab in healthy donors","volume":"12","author":"Spindeldreher","year":"2020","journal-title":"mAbs"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901079","article-title":"Characterization of proinsulin T cell epitopes restricted by type 1 diabetes\u2013associated HLA class II molecules","volume":"204","author":"Ihantola","year":"2020","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00500","article-title":"Characterization of CD4 T cell epitopes of infliximab and rituximab identified from healthy donors","volume":"8","author":"Hamze","year":"2017","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0455-2","article-title":"Large-scale mapping of the Ebola NP and GP proteins reveals multiple immunoprevalent and conserved CD4 T-cell epitopes","volume":"18","author":"Gallais","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800856","article-title":"Healthy donors exhibit a CD4 T cell repertoire specific to the immunogenic human hormone H2-relaxin before injection","volume":"202","author":"Azam","year":"2019","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.07.037","article-title":"Simultaneous monitoring assay for T-cell receptor stimulation-dependent activation of CD4 and CD8 T cells using inducible markers on the cell surface","volume":"571","author":"Takahama","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186998","article-title":"Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells","volume":"12","author":"Reiss","year":"2017","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4049\/jimmunol.1600320","article-title":"Cytokine-independent detection of antigen-specific germinal center T follicular helper cells in immunized nonhuman primates using a live cell activation-induced marker technique","volume":"197","author":"Havenar-Daughton","year":"2016","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-coV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1898831","DOI":"10.1080\/19420862.2021.1898831","article-title":"Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells","volume":"13","author":"Cohen","year":"2021","journal-title":"mAbs"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2015.10.016","article-title":"How many TCR clonotypes does a body maintain","volume":"389","author":"Lythe","year":"2016","journal-title":"J Theor Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201907119","article-title":"A set point in the selection of the \u03b1\u03b2TCR T cell repertoire imposed by pre-TCR signaling strength","volume":"119","author":"Bovolenta","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05555-7","article-title":"Pre-T cell receptor self-MHC sampling restricts thymocyte dedifferentiation","volume":"613","author":"Duke-Cohan","year":"2023","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.752865","article-title":"Pre-T cell receptors (Pre-TCRs) leverage V\u03b2 complementarity determining regions (CDRs) and hydrophobic patch in mechanosensing thymic self-ligands","volume":"291","author":"Das","year":"2016","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1504971112","article-title":"Pre-TCR ligand binding impacts thymocyte development before \u03b1\u03b2TCR expression","volume":"112","author":"Mallis","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe0918","article-title":"Pre\u2013T cell receptors topologically sample self-ligands during thymocyte \u03b2-selection","volume":"371","author":"Li","year":"2021","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.06.005","article-title":"New insights into TCR \u03b2-selection","volume":"42","author":"Dutta","year":"2021","journal-title":"Trends Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201908108","article-title":"Developing T cells form an immunological synapse for passage through the \u03b2-selection checkpoint","volume":"220","author":"Allam","year":"2022","journal-title":"J Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"101702","DOI":"10.1016\/j.smim.2022.101702","article-title":"What\u2019s self got to do with it: Sources of heterogeneity among naive T cells","volume":"65","author":"This","year":"2023","journal-title":"Semin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature05269","article-title":"Thymic selection threshold defined by compartmentalization of Ras\/MAPK signalling","volume":"444","author":"Daniels","year":"2006","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nri3667","article-title":"Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see)","volume":"14","author":"Klein","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/cells9030690","article-title":"Is T cell negative selection a learning algorithm","volume":"9","author":"Wortel","year":"2020","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01550","article-title":"Specificity of the T cell response to protein biopharmaceuticals","volume":"11","author":"Meunier","year":"2020","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308311110","article-title":"Overlapping gene coexpression patterns in human medullary thymic epithelial cells generate self-antigen diversity","volume":"110","author":"Pinto","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4896","article-title":"The Tabula Sapiens: a multiple organ single cell transcriptomic atlas of humans","volume":"376","author":"Jones","year":"2022","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature14475","article-title":"Genome-wide identification of zero nucleotide recursive splicing in Drosophila","volume":"521","author":"Duff","year":"2015","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1084\/jem.20100027","article-title":"Thymus-specific serine protease contributes to the diversification of the functional endogenous CD4 T cell receptor repertoire","volume":"208","author":"Viret","year":"2011","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.646209","article-title":"The role of proteasomes in the thymus","volume":"12","author":"Frantzeskakis","year":"2021","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1182\/blood.2022018937","article-title":"Factor VIII Trafficking to CD4+ T cells Shapes its Immunogenicity and Requires Several Types of Antigen Presenting Cells","volume":"142","author":"Kaczmarek","year":"2023","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1084\/jem.20100027","article-title":"Thymus-specific serine protease contributes to the diversification of the functional endogenous CD4 T cell receptor repertoire","volume":"208","author":"Viret","year":"2011","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5362.450","article-title":"Cathepsin L: critical role in ii degradation and CD4 T cell selection in the thymus","volume":"280","author":"Nakagawa","year":"1998","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01129-x","article-title":"Repertoire analyses reveal T cell antigen receptor sequence features that influence T cell fate","volume":"23","author":"Camaglia","year":"2021","journal-title":"Nat Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00900.x","article-title":"FDA Workshop on factor VIII inhibitors held at the NIH, Bethesda, MA on 21 November 2003","volume":"10","author":"Ingerslev","year":"2004","journal-title":"Haemophilia"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04472.x","article-title":"Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies","volume":"9","author":"Aledort","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00769.x","article-title":"Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis\u2013a meta-analysis","volume":"9","author":"Gruppo","year":"2003","journal-title":"Haemophilia"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005758","article-title":"Influence of N-glycosylation in the A and C domains on the immunogenicity of factor VIII","volume":"6","author":"Vander Kooi","year":"2022","journal-title":"Blood Adv"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640725","article-title":"Tcrmatch: predicting T-cell receptor specificity based on sequence similarity to previously characterized receptors","volume":"12","author":"Chronister","year":"2021","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02762.x","article-title":"T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemostasis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2516.2008.01905.x","article-title":"HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P: DR-RESTRICTED FVIII T-CELL EPITOPES IN A HAEMOPHILIA A FAMILY","volume":"16","author":"Ettinger","year":"2010","journal-title":"Haemophilia"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-200725","article-title":"Lineages of human T-cell clones, including T helper 17\/T helper 1 cells, isolated at different stages of anti\u2013factor VIII immune responses","volume":"114","author":"Ettinger","year":"2009","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017013482","article-title":"FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity","volume":"2","author":"Ettinger","year":"2018","journal-title":"Blood Adv"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-682468","article-title":"T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire","volume":"128","author":"Ettinger","year":"2016","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14647","article-title":"Quantitative HLA-class-II\/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A","volume":"18","author":"Diego","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.175083","article-title":"Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells","volume":"103","author":"Peyron","year":"2018","journal-title":"Haematologica"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M110.002246","article-title":"HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII","volume":"10","author":"van Haren","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1538-7836.2005.01309.x","article-title":"Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII","volume":"3","author":"Jones","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.25","article-title":"Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells","volume":"94","author":"Garnier","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/jha2.319","article-title":"Cd4 + Regulatory and na\u00efve T cells specific for factor VIII stand vis-\u00e0-vis to balance the immune response in healthy individuals","volume":"4","author":"Schmidt","year":"2021","journal-title":"eJHaem"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2007.02336.x","article-title":"Depletion of CD4+\/CD25high regulatory T cells may enhance or uncover factor VIII-specific T-cell responses in healthy individuals","volume":"5","author":"Kamat\u00e9","year":"2007","journal-title":"J Thromb Haemostasis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1345195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:01:44Z","timestamp":1709701304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1345195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":72,"alternative-id":["10.3389\/fimmu.2024.1345195"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1345195","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"article-number":"1345195"}}